The meeting was originally scheduled for 12th November, 2026, as previously intimated on 7th November, 2026. The primary agenda items for this meeting included considering and approving the Unaudited Standalone Financial Results of the Company for the half year ended 30th September, 2026, along with the Limited Review Report thereon.
The Board meeting held on 12th November, 2026, remained inconclusive and has been adjourned. The meeting will reconvene on 13th November, 2026, to consider and conclude the pending agenda items, including the approval of the aforementioned Unaudited Standalone Financial Results.
The Company has committed to making the requisite disclosure to the Stock Exchange upon conclusion of the adjourned Board Meeting.